Michael Thomas Henderson, Director: Spyre Therapeutics SYRE Planned sale · Filed 06/22

Trade details

Type: Planned sale notice
Stock: Spyre Therapeutics SYRE
Person: Michael Thomas HendersonDirector
Planned sale date: 26/06/22
Filed: 26/06/22

More to sell after $6M in 3 months

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 05/23~07/22

Michael Thomas Henderson's recent trades

Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$10.6M
80,000 sh
$10.6M
Filed 06/24
Traded 06/22
Michael Thomas HendersonDirector
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$2M
20,000 sh
$2M
Filed 06/23
Traded 06/22
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$633.6K
7,654 sh
$633.6K
Filed 06/12
Traded 06/10
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$556.6K
6,770 sh
$556.6K
Filed 06/12
Traded 06/10
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$198.9K
2,305 sh
$198.9K
Filed 06/12
Traded 06/10